Yes, it looks pretty obvious that V@lisure is running a scare campaign to boost traffic towards their services. I wonder if there's another play at hand here, t

Yes, it looks pretty obvious that V@lisure is running a scare campaign to boost traffic towards their services. I wonder if there's another play at hand here, though. Did they get in a spat with suppliers? Are they trying to dump the price of ranitidine and nizatidine to buy up at markedly reduced value? Perhaps drive down demand from drugs with less margins towards higher ones? For those downvoting: this is business as usual in entrenched markets like pharmaceuticals -- especially since the FDA has no capacity to enforce anything. And on more thorough review, it looks like the hysteria has spread to many other countries as well -- how quaint. For those that really aren't aware of what good hysteria marketing looks like, please take a look at: https://www.valisure.com/blog/uncategorized/detection-of-ndma-in-raniditine/ https://www.valisure.com/blog/uncategorized/detection-of-ndm... Anyone that works in the world of marketing/PR can see it plainly. I don't feel like digging into what strings they had to pull in order to get this viral, but anyone possessed by curiosity should take a look at their team: https://www.valisure.com/about-us/ https://www.valisure.com/about-us/ After reading their profiles, two members should instantly pop out at you.